Innate Pharma
IPHA
#8517
Rank
โ‚ฌ0.11 B
Marketcap
1,42ย โ‚ฌ
Share price
-7.98%
Change (1 day)
-40.06%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2022: โ‚ฌ49.58 Million

According to Innate Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ50.4 Million. In 2022 the company made a revenue of โ‚ฌ49.58 Million an increase over the revenue in the year 2021 that were of โ‚ฌ12.11 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2022

Annual revenue

Year Revenue Change
2022โ‚ฌ49.58 M309.41%
2021โ‚ฌ12.11 M-78.43%
2020โ‚ฌ56.15 M-18.15%
2019โ‚ฌ68.6 M-14.12%
2018โ‚ฌ79.89 M144.83%
2017โ‚ฌ32.63 M-41.9%
2016โ‚ฌ56.16 M213.64%
2015โ‚ฌ17.9 M1874.2%
2014โ‚ฌ0.9 M-92.73%
2013โ‚ฌ12.46 M20.16%
2012โ‚ฌ10.37 M39.21%
2011โ‚ฌ7.45 M72.55%
2010โ‚ฌ4.32 M-44.01%
2009โ‚ฌ7.71 M-40.3%
2008โ‚ฌ12.92 M-9.56%
2007โ‚ฌ14.29 M68.57%
2006โ‚ฌ8.47 M246.85%
2005โ‚ฌ2.44 M